Direct Answer
Victoza is not approved as a weight loss drug, but it often leads to measurable weight reduction in people with type 2 diabetes. The effect is real, yet it comes with important limits and risks that anyone considering it should understand.
More from this site
Keep reading the latest coverage
How Victoza Works
Liraglutide, the active ingredient in Victoza, mimics a gut hormone called GLP-1. It slows stomach emptying, reduces appetite, and helps the pancreas release insulin when blood sugar is high. These actions together often result in lower calorie intake and gradual weight loss.
What the Evidence Shows
Clinical trials for Victoza documented weight loss in type 2 diabetes patients, but the studies were designed to measure blood sugar control, not weight loss as the primary outcome. The amount of weight lost varies widely and depends on dose, diet, activity level, and starting weight. Some patients lose a modest amount, while others see little change.
Approved Uses vs Off-Label Use
The FDA has approved Victoza for type 2 diabetes management, not for weight loss in people without diabetes. Using a medication off-label is legal when a doctor determines it is medically appropriate, but insurers may not cover it, and the safety profile outside diabetes is less established.
Risks and Side Effects
Common side effects include nausea, vomiting, diarrhea, and constipation. More serious risks include pancreatitis, gallbladder problems, and a boxed warning for thyroid C-cell tumors observed in animal studies. Victoza is not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
When Weight Loss Is the Primary Goal
For weight management without diabetes, other GLP-1 receptor agonists such as semaglutide (Wegovy) are approved and specifically studied for chronic weight management. A doctor can help determine whether Victoza makes sense for an individual's situation or whether a different treatment is more appropriate.